Medication Comparison

Ozempic vs Mounjaro

Mounjaro (tirzepatide) achieves significantly more weight loss than Ozempic (semaglutide) due to its dual GLP-1/GIP mechanism. Both are FDA-approved for type 2 diabetes. For weight loss, Mounjaro is used off-label while its sister product Zepbound has the obesity approval.

Category Ozempic Mounjaro
Brands Ozempic (semaglutide) Mounjaro (tirzepatide)
Class GLP-1 RA GLP-1/GIP dual agonist
Administration Weekly injection Weekly injection
Average weight loss ~6-10% ~15-22%
Compounded cost $900-1,100/mo (brand) $1,000-1,200/mo (brand)
Brand cost $900-1,100/mo $1,000-1,200/mo
Half-life ~7 days ~5 days
Dosing frequency Once weekly Once weekly
Key trial SUSTAIN trials SURPASS trials (up to 22.5% weight loss)

Best for Ozempic

Patients wanting a proven diabetes medication with good weight-loss side benefit

Best for Mounjaro

Patients with diabetes who also want maximum weight reduction

Ozempic tradeoffs

Pros

  • Longer track record
  • Well-studied safety profile
  • Oral version available (Rybelsus)

Cons

  • Single-receptor mechanism
  • Lower weight loss than Mounjaro

Mounjaro tradeoffs

Pros

  • Dual mechanism targets GLP-1 and GIP
  • Greater weight loss
  • Strong A1C reduction

Cons

  • Only approved for diabetes (not obesity)
  • Newer drug with less long-term data

Common questions

Is Mounjaro better than Ozempic?

For weight loss, clinical data shows Mounjaro (tirzepatide) produces greater weight reduction than Ozempic (semaglutide). For blood sugar control, Mounjaro also showed superior A1C reduction in the SURPASS-2 trial.

Can I switch from Ozempic to Mounjaro?

Yes, your doctor can transition you. You would typically start Mounjaro at the lowest dose (2.5mg) regardless of your Ozempic dose, then titrate up.

Do they have the same side effects?

Both share similar GI side effects (nausea, diarrhea, vomiting). The frequency is comparable, though individual experiences vary.

Compare clinics that prescribe these medications

Use provider pages to compare clinical oversight, medication source, and pricing transparency before starting.

View Providers